Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.32
+0.12 (0.91%)
Jun 18, 2026, 4:08 PM HKT

HKG:1681 Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, HKG:1681 stock has a consensus rating of "Buy" and an average price target of $23.75. The average 1-year stock price forecast is 78.30% higher than the current stock price, while the lowest is $21.58 (+62.01%) and the highest is $26.59 (+99.62%).

Price Target: $23.75 (+78.30%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$21.58$23.75$23.09$26.59
Change+62.01%+78.30%+73.35%+99.62%
* Price targets were last updated on Apr 23, 2026.

Analyst Ratings

The average analyst rating for HKG:1681 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25Aug '25Sep '25Mar '26Apr '26
Strong Buy101111
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total323333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Guoyuan Securities (HK)
No rating
Guoyuan Securities (HK)
Buy
Maintains
$21.40
BuyMaintains$21.40+60.66%Apr 23, 2026
Unknown Analyst
First Shanghai Securities
No rating
First Shanghai Securities
Buy
Maintains
$25.30
BuyMaintains$25.30+89.94%Apr 16, 2026
DBS
DBS
Buy
Maintains
$26.00
BuyMaintains$26.00+95.20%Mar 27, 2026

Financial Forecast

Revenue This Year
3.88B
from 3.42B
Increased by 13.60%
Revenue Next Year
4.35B
from 3.88B
Increased by 12.07%
EPS This Year
1.47
from 1.26
Increased by 16.89%
EPS Next Year
1.62
from 1.47
Increased by 10.07%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.04B2.34B2.59B2.97B3.42B3.88B
Revenue Growth
16.65%14.43%10.71%14.56%15.17%13.60%
Gross Profit
1.53B1.76B1.92B2.24B2.67B3.06B
Gross Margin
74.70%75.35%74.19%75.56%78.05%78.70%
Operating Income
660.18M715.41M825.92M974.99M1.15B1.40B
Net Income
590.17M682.91M784.53M910.46M1.08B1.24B
EPS
----1.261.47
EPS Growth
----16.16%16.89%
Forward PE
3.804.184.096.579.817.81
Dividend / Share
0.240.270.410.560.660.74
Dividend Growth
-8.58%53.93%38.03%16.35%12.64%
Free Cash Flow
464.15M650.74M507.99M681.72M-208.28M912.00M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High3.9B
Avg3.9B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
14.3%
Avg
13.6%
Low
12.9%

EPS Forecast

EPS202620272028
High1.48
Avg1.47
Low1.47

EPS Growth

EPS Growth202620272028
High
17.1%
Avg
16.9%
Low
16.7%